Nikhil Prasad Fact checked by:Thailand Medical News Team Jul 17, 2026 1 hour, 20 minutes ago
Medical News: A new genetic study has uncovered fresh clues about how inherited risk for Alzheimer’s disease may influence the brain, highlighting specific biological pathways linked to memory, brain support cells, metabolism, and inflammation. The findings suggest that the disease may develop through a more targeted set of biological processes than previously believed, opening the door to more personalized treatment strategies.
New genetic research reveals that Alzheimer’s risk is strongly linked to memory, metabolism, astrocytes,
and immune pathways rather than broad aging processes
The research was conducted by Ngo Cheung from the Independent Researcher, Hong Kong-China. Using advanced genetic analysis, the study explored how inherited DNA variations influence gene activity across different regions of the brain rather than focusing only on individual risk genes.
Looking Beyond Individual Alzheimer’s Genes
Many genetic changes linked to Alzheimer’s disease occur outside genes themselves, making it difficult to understand exactly how they contribute to disease. To overcome this challenge, the researcher used a transcriptome-wide association study (TWAS), a technique that predicts how genetic variations affect gene activity in brain tissue.
The analysis examined six brain regions involved in memory, thinking, and decision-making, while testing more than 40 biological pathways connected with inflammation, energy production, aging, brain cell communication, and metabolism.
Memory Pathway Emerges as the Strongest Signal
One of the biggest surprises was that the strongest positive signal involved long-term potentiation (LTP), the process that allows brain cells to strengthen their connections during learning and memory formation.
Instead of showing widespread disruption across all forms of brain communication, the study found that inherited Alzheimer’s risk appears to focus specifically on this highly specialized memory-building mechanism. Important genes involved in calcium signaling, cellular communication, and memory-related protein activity contributed strongly to this finding.
The results suggest that subtle changes affecting how memories are formed and maintained could begin long before symptoms of Alzheimer’s become obvious.
Brain Support Cells and Metabolism Also Play Major Roles
Another major finding involved astrocytes, the star-shaped support cells that nourish neurons, regulate brain chemistry, and help maintain healthy brain function. These cells showed stronger genetic involvement than microglia, another important immune cell in the brain.
The study also identified increased activity in pathways linked to insulin signaling, GLP-1 signaling, and the PI3K-AKT-mTOR pathway. These systems help regulate how brain cells use energy and respond to nutrients. Their involvement adds further evidence connecting Alzheimer’s disease with metabolic dysfunction and may help explain growing interest in GLP-1-based medications that are already being investigated for Alzheime
r’s treatment.
This
Medical News report highlights that the metabolic signals were consistent across multiple brain regions, suggesting they represent genuine inherited risk factors rather than isolated genetic events.
Unexpected Findings About Aging and Brain Energy
Perhaps the most surprising discovery involved cellular aging. While many scientists have suspected that cellular senescence—a process in which damaged cells stop dividing—drives Alzheimer’s disease, this study found the opposite pattern genetically.
Genes responsible for regulating cellular senescence consistently showed lower activity among inherited Alzheimer’s risk pathways. Likewise, genes involved in oxidative phosphorylation, the process that allows mitochondria to generate energy for cells, also displayed a strong negative pattern.
Rather than suggesting these processes are unimportant, the findings indicate they may become altered later in disease progression instead of serving as the primary inherited drivers.
Researchers also found that complement-related immune activity was strongly associated with Alzheimer’s risk, largely because of the well-known CR1 gene. However, broader synapse-pruning pathways behaved differently, indicating that not all immune mechanisms contribute equally to disease development.
Conclusions
The study paints a far more detailed picture of Alzheimer’s disease than earlier genetic investigations. Instead of affecting the brain through one broad mechanism, inherited risk appears to target a combination of memory formation, astrocyte function, immune signaling, and metabolic regulation while showing surprisingly reduced involvement of traditional aging pathways. These insights could help researchers identify patients based on their dominant biological pathways and support the development of precision treatments tailored to individual disease mechanisms rather than relying on one universal therapy.
The study findings were published in the peer reviewed Journal of Alzheimer's Disease Reports.
https://journals.sagepub.com/doi/full/10.1177/25424823261468711
For the latest on Alzheimer’s Disease, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/alzheimer,-dementia-